{"id":1482,"date":"2004-08-01T12:06:00","date_gmt":"2004-08-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/therapie-der-lepra-und-der-lepra-neuropathie"},"modified":"2004-08-01T12:06:00","modified_gmt":"2004-08-01T10:06:00","slug":"therapie-der-lepra-und-der-lepra-neuropathie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/therapie-der-lepra-und-der-lepra-neuropathie","title":{"rendered":"Therapie der Lepra und der Lepra-Neuropathie"},"content":{"rendered":"<p>Im Brit. Med. J. erschienen k\u00fcrzlich zwei Artikel zur Therapie der Lepra (1, 2), einer der wichtigsten chronischen Infektionskrankheiten warmer L\u00e4nder, die im Mittelalter auch in unseren Breiten bei den Betroffenen zu katastrophalen Folgen gef\u00fchrt hat. Weltweit sind ca. 1,2 Mio. Menschen an Lepra erkrankt, die meisten davon in Indien, und j\u00e4hrlich erkranken ca. 700000 [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Brit. Med. J. erschienen k\u00fcrzlich zwei Artikel zur Therapie der Lepra (1, 2), einer der wichtigsten chronischen Infektionskrankheiten warmer L\u00e4nder, die im Mittelalter auch in unseren Breiten bei den Betroffenen zu katastrophalen Folgen gef\u00fchrt hat. Weltweit sind ca. 1,2 Mio. Menschen an Lepra erkrankt, die meisten davon in Indien, und j\u00e4hrlich erkranken ca. 700000 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[246,247,244,3511,241,243],"class_list":["post-1482","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-glukokortikoide","tag-glukokortikosteroide","tag-kortikosteroide","tag-lepra","tag-prednisolon","tag-prednison"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1482"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1482\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}